Jeff Shon | Director, Quest Pharmatech Inc

Jeff Shon | Director, Quest Pharmatech Inc

  • Jeff is a Director with Quest Pharmatech Inc.
  • He is also the Partner & Funds Manager with REDDS Capital.

Podcast

Overview

In this episode, we have with us Jeff Shon, a multifaceted professional with a deep involvement in investments, startups, and innovation. Jeff offers insights into the world of venture capital and angel investing. Additionally, his roles as a director in pharmaceutical companies, involvement in the startup community, and participation in the AI for Good initiative provide a comprehensive view of his commitment to fostering impactful innovation. Join us as we delve into Jeff’s journey, experiences, and valuable advice for aspiring entrepreneurs and investors alike.

[00:34] – About Jeff Shon

  • Jeff is a Director with Quest Pharmatech Inc.
  • He is also the Partner & Funds Manager with REDDS Capital.
  • Jeff has studied law and holds experience in the legal and finance sectors. 

[08:57] – Could you describe your roles at the TSX Venture Exchange, particularly in corporate finance and compliance?

  • Corporate finance involves attracting private companies to access public funding. 
  • It required comprehensive due diligence, including legal, financial, and product assessments. 
  • Compliance focused on maintaining market integrity by ensuring companies met statutory disclosure requirements. 
  • Both roles considered the impact of decisions on the broader market.

[10:19] –  As a director in a pharmaceutical company, what responsibilities does your role entail?

  • I provide a sober second thought for the CEO and the board. 
  • We offer an interdisciplinary approach to decision-making, advise on significant decisions, and oversee committees. 
  • My current roles include heading the compensation and governance committees.

[16:17] – What is your role in the ‘AI for Good’ initiative?  How does it impact the world of AI innovation?

  • AI for Good is a leading AI conference with an innovation program. 
  • I serve as a judge, evaluating promising AI companies globally. 
  • Due diligence is a critical part of my role, assessing their potential for impact.
  • This allows us to invest in groundbreaking AI innovation that can address global challenges.

RESOURCES:

You can connect with Jeff Shon: LinkedIn 

Enjoyed this podcast?

If you learned new insights about the world of investments and AI, subscribe and share it with friends! 

Love to give us 5 stars? ⭐⭐⭐⭐⭐ If you do, we’d love a review from you. Help us reach more people to keep them in the know as we talk to leaders, high achievers, and thought leaders from diverse backgrounds and nationalities. Excellence can come from anywhere; stay in the know, and hear from emergent high achievers and gurus.

Stay updated with what’s shaping the world today through the latest The Brand Called You Podcast episode. Follow us on iTunes, Spotify, and Anchor.fm.  

You can find us at:

Website: www.tbcy.in 

Instagram: http://bit.ly/3HO7N06 

Facebook:http://bit.ly/3YzJOaD 

Twitter: http://bit.ly/3wMBOXK 

LinkedIn: https://www.linkedin.com/company/tbcy/ 

YouTube: http://bit.ly/3jmBqfq 

Chingari: https://chingari.io/tbcypodcast 

Moj:http://bit.ly/3wOrmPv 

Josh: http://bit.ly/3WWP0nB 

Thanks for listening! 

Profile

  • Jeff is a Director with Quest Pharmatech Inc.
  • He is also the Partner & Funds Manager with REDDS Capital.
  • Jeff has studied law and holds experience in the legal and finance sectors. 

Leave a Reply

Your email address will not be published. Required fields are marked *